INIVATA
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.
INIVATA
Industry:
Biotechnology Genetics Health Care Medical Device
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.inivata.com
Total Employee:
51+
Status:
Active
Contact:
(440) 207-6389
Email Addresses:
[email protected]
Total Funding:
164.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Nginx Amazon Person Schema GStatic Google Static Content Gravatar Profiles Apple Mobile Web App Capable
Similar Organizations
BioIntelliSense
BioIntelliSense, a continuous health monitoring and clinical intelligence company with medical-grade wearable devices and Data-as-a-Service.
Color
Color is a complete platform for healthcare delivery.
Helix
Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Inivata
Soleus Capital
Soleus Capital investment in Series C - Inivata
Farallon Capital Management
Farallon Capital Management investment in Series C - Inivata
NeoGenomics
NeoGenomics investment in Corporate Round - Inivata
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series B - Inivata
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - Inivata
IP Group
IP Group investment in Series B - Inivata
RT Ventures
RT Ventures investment in Series B - Inivata
Woodford Investment Management
Woodford Investment Management investment in Series B - Inivata
Future Planet Capital
Future Planet Capital investment in Series B - Inivata
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-13 | Inivata Appoints David Eberhard MD, PhD as Chief Medical Officer |
Official Site Inspections
http://www.inivata.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.04 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inivata" on Search Engine
NeoGenomics to Acquire Inivata - Combining Best-In-Class …
May 5, 2021 Inivata will become a liquid biopsy focused division alongside NeoGenomics' growing clinical, pharma and informatics divisions. Current Inivata Chief Executive …See details»
NeoGenomics Completes Inivata Acquisition - Combining Best-In …
Jun 18, 2021 Inivata will become a liquid biopsy focused division alongside NeoGenomics' growing clinical, pharma and informatics divisions. Inivata Chief Executive Officer, Dr. …See details»
NeoGenomics to acquire Inivata for $390M after success of lung …
May 6, 2021 The original mid-2020 partnership saw NeoGenomics invest $25 million into Inivata to become a minority owner of the U.K.-based genetic test maker, with an option …See details»
Inivata - Funding, Financials, Valuation & Investors - Crunchbase
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.See details»
Inivata to be Acquired by NeoGenomics - Yahoo Finance
May 5, 2021 Inivata, with its leading liquid biopsy technology platform, will remain a separate business division alongside NeoGenomics’ growing clinical, pharma and …See details»
Inivata | LinkedIn
About us. Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients.See details»
NeoGenomics Completes Inivata Acquisition - Yahoo Finance
Jun 18, 2021 Inivata will become a liquid biopsy focused division alongside NeoGenomics' growing clinical, pharma and informatics divisions. Inivata Chief Executive Officer, Dr. …See details»
Inivata notes completion of acquisition by NeoGenomics
Established in 2014, Inivata is a clinical liquid biopsy company focussed on harnessing the potential of circulating tumour DNA. Inivata’s technology platform is based on pioneering …See details»
NeoGenomics to Acquire Inivata - Combining Best-In-Class …
May 5, 2021 Inivata will become a liquid biopsy focused division alongside NeoGenomics' growing clinical, pharma and informatics divisions. Current Inivata Chief Executive …See details»
Inivata Company Profile - Office Locations, Competitors ... - Craft
Inivata is a clinical cancer genomics company focused on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment.See details»
FDA Grants Breakthrough Device Designation for Inivata’s
Mar 9, 2021 The program provides patients and healthcare providers with timely access to these medical devices by expediting their development, assessment, and review, while …See details»
PRESS RELEASE: Inivata And The European Organisation For …
Oct 29, 2019 InVisionFirst-Lung is a ctDNA next generation sequencing liquid biopsy capable of testing 36 genes, including ALK, relevant to the care of patients with …See details»
Inivata to be acquired by NeoGenomics – Company …
May 5, 2021 The Company (LSE: SUPP) is pleased to announce that portfolio company Inivata Limited ("Inivata"), a leader in liquid biopsy, has announced its acquisition by …See details»
Portfolio company Inivata announces collaboration and …
May 26, 2020 Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, is …See details»
Inivata - Updates, News, Events, Signals & Triggers - Crunchbase
Inivata is focused on advancing the detection of cancer DNA through highly sensitive methods. Their research involves sequencing multiple aliquots of a DNA sample from a …See details»
Inivata - Cambridge Innovation Capital
Inivata - Cambridge Innovation Capital. Companies Inivata. Inivata is a leader in liquid biopsy. Spotlight. Inivata’s liquid biopsy products provide essential genetic insights into …See details»
UEZ Cambridge - Inivata | Connect Health Tech
Through successful clinical collaborations and validation work, Inivata was able to raise an early investment of £4 million from Cambridge Innovation Capital, Imperial Innovations …See details»
Inivata Ltd - Product Pipeline Analysis, 2023 Update - Research …
Inivata Ltd (Inivata), a subsidiary of NeoGenomics Inc., is a cancer genomics company that harnesses liquid biopsy platforms to enhance personalized healthcare in oncology.See details»
Inivata - Contacts, Employees, Board Members, Advisors & Alumni
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.See details»
Inivata Launches US Clinical Trial of Innovative ctDNA Liquid …
Oct 13, 2016 Inivata, a global clinical cancer genomics company employing a revolutionary approach to circulating tumor DNA (ctDNA) analysis to improve personalized healthcare …See details»